P-glycoprotein functional activity in «soviet chinchilla» rabbits during pregnancy

Abstract

P-glycoprotein (Pgp, ABCB1-protein) is a membrane transporter protein that plays the key role in pharmacokinetics of drugs with a broad spectrum of action. Substrates of this transporter are some medical drugs (antibacterial, antiretroviral, hypotensive) that are prescribed to pregnant women for long-term intake, sometimes throughout the whole gestation period.

Aim to study the activity of Pgp on the organism level in rabbits of Soviet Chinchilla breed in pregnancy.

Materials and Methods. The study was performed on 21 Soviet Chinchilla female rabbits (3000-3500 g). The animals were divided into 3 series. The first series (n=6) included rabbits with 7 days of pregnancy; the second series (n=5) − animals with 14 days of pregnancy; the third series (n=10) − rabbits with 21 days of pregnancy. 7 Days before the study and in the indicated gestation periods, functional activity of Pgp was assessed by the pharmacokinetics of marker transporter substrate – fexofenadine, after its single oral introduction (67.5 mg/kg). Besides, serum concentrations of progesterone, estradiol, testosterone and prolactin were determined by radio immune method

Results. In all the studied gestational periods, serum concentrations of estradiol, testosterone and prolactin did not significantly differ from those before pregnancy, but the level of progesterone in blood serum was significantly elevated above the norm. On the 7^th day of pregnancy pharmacokinetic parameters of fexofenadine did not show any reliable changes as compared to the initial va-lues. On the 14^th day of pregnancy a reliable increase in C_max, AUC_0-t, T_1/2 of fexofenadine was noted as compared to the parameters before pregnancy, which indicates a decrease in Pgp functional activity on the organism level. On the 21^st day of pregnancy C_max of fexofenadine remained elevated. Other pharmacokinetic parameters of fexofenadine did not show reliable changes. Conclusion. Reduction in Pgp functional activity, determined by the pharmacokinetics of its marker substrate (fexofenadine), was noted in rabbits of Soviet Chinchilla breed on the 14^th and 21^st days of pregnancy with the underlying significant increase in progesterone level.

Keywords

P-glycoprotein / ABCB1-protein / functional activity / pregnancy / progesterone

References

[1] Zhuravleva ЕО, Velts NYu, Zatolochina KE., et al. Analysis of Spontaneous Reports of Adverse Reactions, Developed in the Use of Drugs During Pregnancy. Safety and Risk of Pharmacotherapy. 2017; 5(2):61-9. (In Russ).

[2] Журавлева Е.О., Вельц Н.Ю., Затолочина К.Э., и др. Анализ спонтанных сообщений о нежелательных реакциях, развившихся при применении лекарственных средств во время беременности // Безопасность и риск фармакотерапии. 2017. Т. 5, №2. С. 61-69.

[3] Kukes VG, Grachev SV, Sychev DA, et al. Metabolizm lekarstvennykh sredstv. Nauchnyye osnovy personalizovannoy meditsiny. Rukovodstvo dlya vrachey. Moscow: GEOTAR-Media; 2008. (In Russ).

[4] Кукес В.Г., Грачев С.В., Сычев Д.А., и др. Метаболизм лекарственных средств. Научные основы персонализованной медицины. Руководство для врачей. М.: ГЭОТАР-Медиа; 2008.

[5] Yakusheva EN, Chernykh IV, Biruicova AS. Characteristic of P-glycoprotein as a drug peptide transporter. I.P. Pavlov Russian Medical Biological Herald. 2011;3:142-48. (In Russ).

[6] Якушева Е.Н., Черных И.В., Бирюкова А.С. Характеристика гликопротеина-Р как белка транспортера лекарственных веществ // Российский медико-биологический вестник имени академика И.П. Павлова. 2011. №3. С. 142-148.

[7] Shchulkin AV, Chernykh IV, Yakusheva EN, et al. Estradiol influence on functioning of ABCB1-protein in experiment. Vestnik Ural'skoi Meditsin skoi Akademicheskoi Nauki. 2017;14(4):427-34. (In Russ). doi:10. 22138/2500-0918-2017-14-4-427-434

[8] Щулькин А.В., Черных И.В., Якушева Е.Н., и др. Влияние эстрадиола на функционирование ABCB1-белка в эксперименте // Вестник Уральской медицинской академической науки. 2017. Т. 14, №4. С. 427-434. doi:10.22138/2500-0918-2017-14-4-427-434

[9] Shchul’kin AV, Chernykh IV, Yakusheva EN, et al. Influence of Progesterone on P-Glycoprotein Functional Activity in Experiment. Pharmaceutical Chemistry Journal. 2018;52(7):3-8. (In Russ). doi:10.30906/0023-1134-2018-52-7-3-8

[10] Щулькин А.В., Черных И.В., Якушева Е.Н., и др. Влияние прогестерона на функциональную активность гликопротеина-P в эксперименте // Химико-фармацевтический журнал. 2018. Т. 52, №7. С. 3-8. doi:10.30906/0023-1134-2018-52-7-3-8

[11] Shmagel’ КV, Chereshnev VА. Steroid Hormones. Their Physiological Role and Diagnostic Value During Pregnancy. Uspekhi Fiziologicheskikh Nauk. 2004;35(3):61-71. (In Russ).

[12] Шмагель К.В., Черешнев В.А. Стероидные гормоны: физиологическая роль и диагностическое значение в период беременности // Успехи физиологических наук. 2004. Т. 35, №3. С. 61-71.

[13] Gatsanoga MV, Chernykh IV, Shchulkin AV, et al. The method of assessment of drugs belonging to the substrates of P-glycoprotein on female rabbits. Nauka molodykh (Eruditio Juvenium). 2016;3:5-10. (In Russ).

[14] Гацанога М.В., Черных И.В., Щулькин А.В., и др. Можно ли оценивать принадлежность лекарственных веществ к субстратам гликопротеина-P на самках кроликов породы шиншилла // Наука молодых (Eruditio Juvenium). 2016. №3. С. 5-10.

[15] Yakusheva EN, Chernykh IV. Finasteride influence on P-glycoprotein functional activity. I.P. Pavlov Russian Medical Biological Herald. 2012;4:46-50. (In Russ).

[16] Якушева Е.Н., Черных И.В., Влияние финастерида на функциональную активность гликопротеина-Р в эксперименте // Российский медико-биологический вестник имени академика И.П. Павлова. 2012. №4. С. 46-50.

[17] Karkishchenko NN, Khoronko VV, Sergeeva SA, et al. Farmakokinetika. Rostov-na-Donu: Feniks; 2001. (In Russ).

[18] Каркищенко Н.Н., Хоронько В.В., Сергеева С.А., и др. Фармакокинетика. Ростов н/Д: Феникс; 2001.

[19] Tinayev N.I. Razvedeniye krolikov. Moscow: Kompaniya Del'ta M; 2004. (In Russ).

[20] Тинаев Н.И. Разведение кроликов. М.: Компания Дельта М; 2004.

[21] Fröhlich M, Albermann N, Sauer A, et al. In vitro and ex vivo evidence for modulation of P-glycoprotein activity by progestins. Biochemical Pharmacology. 2004;68(12):2409-16. doi:10.1016/ j.bcp.2004.08.026

[22] Fröhlich M., Albermann N., Sauer A., et al. In vitro and ex vivo evidence for modulation of P-glycoprotein activity by progestins // Biochemical Pharmacology. 2004. Vol. 68, №12. P. 2409-2416. doi:10.1016/j.bcp.2004.08.026

[23] Yang CP, De Pinho SG, Greenberger LM, et al. Progesterone interacts with P-glycoprotein in multidrug-resistant cells and in the endometrium of gravid uterus. Journal of Biological Chemistry. 1989;264(2):782-8.

[24] Yang C.P., De Pinho S.G., Greenberger L.M., et al. Progesterone interacts with P-glycoprotein in multidrug-resistant cells and in the endometrium of gravid uterus // Journal of Biological Chemistry. 1989. Vol. 264, №2. P. 782-788.

[25] Coles LD, Lee IJ, Voulalas PJ, et al. Estradiol and Progesterone-Mediated Regulation of P-gp in P-gp Overexpressing Cells (NCI-ADR-RES) and Placental Cells (JAR). Molecular Pharmaceutics. 2009; 6(6):1816-25. doi:10.1021/mp900077q

[26] Coles L.D., Lee I.J., Voulalas P.J., et al. Estradiol and Progesterone-Mediated Regulation of P-gp in P-gp Overexpressing Cells (NCI-ADR-RES) and Placental Cells (JAR) // Molecular Pharmaceutics. 2009. Vol. 6, №6. P. 1816-1825. doi:10.1021/mp900077q

RIGHTS & PERMISSIONS

Popova N.M., Shchulkin A.V., Chernykh I.V., Esenina A.S., Gradinar M.M., Nikiforova L.V., Ryabkov A.N., Yakusheva E.N.